Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Idiotypy of catecholamine-binding proteins.

A D Strosberg, S Chamat, J G Guillet

    Annales De L'Institut Pasteur. Immunologie
    |January 1, 1985
    PubMed
    Summary

    This study explores the immune response to alprenolol, a beta-adrenergic antagonist. Researchers found that anti-alprenolol antibodies mimic beta-adrenergic receptors and an anti-idiotypic antibody acts like an agonist.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Immunological studies of hormone receptors: a two-way approach.

    Immunology today·2014
    Same author

    The pea lectin gene family contains only one functional gene.

    Plant molecular biology·2013
    Same author

    Lectin-gene expression in pea (Pisum sativum L.) roots.

    Planta·2013
    Same author

    Dimerization-driven interaction of hepatitis C virus core protein with NS3 helicase.

    The Journal of general virology·2010
    Same author

    Human papillomavirus 16-specific T cell responses in classic HPV-related vulvar intra-epithelial neoplasia. Determination of strongly immunogenic regions from E6 and E7 proteins.

    Clinical and experimental immunology·2009
    Same author

    Peptide inhibitors of hepatitis C virus core oligomerization and virus production.

    The Journal of general virology·2009

    Area of Science:

    • Immunology
    • Pharmacology
    • Biochemistry

    Background:

    • The immune system's response to drugs, specifically the idiotypic and anti-idiotypic networks, is complex.
    • Alprenolol is a beta-adrenergic antagonist with implications for cardiovascular and other physiological processes.

    Purpose of the Study:

    • To investigate the idiotypic and anti-idiotypic immune responses to alprenolol in rabbits and mice.
    • To characterize the binding properties and genetic basis of anti-alprenolol antibodies.
    • To explore the functional, agonist-like properties of anti-idiotypic antibodies targeting beta-adrenergic receptors.

    Main Methods:

    • Production and characterization of rabbit polyclonal and mouse monoclonal antibodies against alprenolol.
    • Analysis of antibody binding affinities and specificities using catecholamine analogs.

    Related Experiment Videos

  • N-terminal sequencing and gene restriction mapping of antibody chains.
  • Western blot, immunoprecipitation, and immunofluorescence to assess receptor recognition.
  • Measurement of catecholamine-sensitive adenylate cyclase activity.

    • Main Results:

    • Rabbit anti-alprenolol antibodies exhibited binding similar to beta-adrenergic receptors.
    • Mouse monoclonal anti-alprenolol antibodies showed variable affinities, primarily utilizing gamma 1 and gamma 2a heavy chain classes.
    • Antibody sequencing and gene mapping suggested the use of uncommon antibody gene subgroups.
    • The anti-idiotypic response varied depending on the specific monoclonal antibody used.
    • A monoclonal anti-idiotypic antibody demonstrated agonist-like activity at beta-adrenergic receptors, stimulating adenylate cyclase, an effect blocked by propranolol.

    Conclusions:

    • Anti-alprenolol antibodies can mimic the binding characteristics of beta-adrenergic receptors.
    • The anti-idiotypic antibody generated against anti-alprenolol antibodies possesses functional agonist-like properties.
    • This research provides insights into the immune system's ability to generate antibodies with receptor-like functions and potential therapeutic implications.